Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid

BACKGROUND: Bempedoic acid (BA) inhibits ATP‐citrate lyase in the cholesterol synthesis pathway and lowers low‐density lipoprotein cholesterol (LDL‐C). As with other lipid‐lowering therapies, interindividual variation in response to BA was observed in clinical trials. We characterized LDL‐C response...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballantyne, Christie M., Bays, Harold E., Louie, Michael J., Smart, Jeremy, Zhang, Yang, Ray, Kausik K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375471/
https://www.ncbi.nlm.nih.gov/pubmed/35916348
http://dx.doi.org/10.1161/JAHA.121.024531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375471/
https://www.ncbi.nlm.nih.gov/pubmed/35916348
http://dx.doi.org/10.1161/JAHA.121.024531

Ejemplares similares